ZAI LAB LTD's ticker is ZLAB and the CUSIP is 98887Q104. A total of 157 filers reported holding ZAI LAB LTD in Q1 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,589,541 | -12.3% | 394,469 | 0.0% | 0.01% | -8.3% |
| Q2 2023 | $10,938,625 | -9.7% | 394,469 | +8.3% | 0.01% | -14.3% |
| Q1 2023 | $12,117,915 | +22.5% | 364,339 | +13.1% | 0.01% | +16.7% |
| Q4 2022 | $9,888,593 | +547.6% | 322,104 | +621.5% | 0.01% | +500.0% |
| Q3 2022 | $1,527,000 | -93.1% | 44,642 | -93.0% | 0.00% | -92.3% |
| Q2 2022 | $22,204,000 | -21.1% | 640,225 | 0.0% | 0.03% | -10.3% |
| Q1 2022 | $28,158,000 | -28.2% | 640,225 | +2.6% | 0.03% | -27.5% |
| Q4 2021 | $39,203,000 | -53.4% | 623,768 | -21.8% | 0.04% | -57.0% |
| Q3 2021 | $84,084,000 | -33.8% | 797,836 | +11.2% | 0.09% | -31.6% |
| Q2 2021 | $126,966,000 | +2167.7% | 717,365 | +1609.4% | 0.14% | +2166.7% |
| Q1 2021 | $5,599,000 | +17961.3% | 41,965 | +18066.7% | 0.01% | – |
| Q4 2020 | $31,000 | +121.4% | 231 | +34.3% | 0.00% | – |
| Q3 2020 | $14,000 | +55.6% | 172 | +53.6% | 0.00% | – |
| Q2 2020 | $9,000 | – | 112 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRILLIANCE ASSET MANAGEMENT LTD | 1,631,887 | $71,770,000 | 28.24% |
| Zeal Asset Management Ltd | 351,829 | $15,234,000 | 19.86% |
| Tree Line Advisors (Hong Kong) Ltd. | 460,000 | $20,231,000 | 11.97% |
| INDUS CAPITAL PARTNERS, LLC | 291,026 | $12,799,000 | 5.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 78,958 | $16,958,000 | 3.82% |
| HSG Holding Ltd | 694,634 | $30,550,000 | 3.81% |
| EcoR1 Capital, LLC | 2,223,212 | $97,777,000 | 3.06% |
| Segantii Capital Management Ltd | 2,252,274 | $99,055,000 | 2.86% |
| Privium Fund Management B.V. | 226,752 | $9,973,000 | 2.20% |
| Genesis Investment Management, LLP | 820,352 | $36,079,000 | 2.12% |